Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study

Bulky non-small cell lung cancer (NSCLC) is difficult to achieve effective local control by conventionally fractionated radiotherapy. The present work aims to evaluate the safety and efficacy of partial stereotactic ablative boost radiotherapy in bulky NSCLC.
Dove Medical